Trial intelligence / Profile preview

Acyclovir for Prevention of Chemotherapy-Induced Oral Mucositis in Autologous HSCT

KCT0003885Phase 2Completed

Sponsor
Seoul National University Hospital
Start
Jun 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of aciclovir in stomatitis, sponsored by Seoul National University Hospital. Started Jun 2019; status: completed.

02

Drugs

aciclovir
03

Conditions

stomatitis

Beyond the preview

Go deeper on KCT0003885.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0003885.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call